Skip to main content
EDEN RESEARCH PLC logo

EDEN RESEARCH PLC — Investor Relations & Filings

Ticker · EDEN ISIN · GB0001646941 LEI · 213800ZWTYTVQQSM3J85 IL Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2020-02-28 Capital/Financing Update
Country GB United Kingdom
Listing IL EDEN

About EDEN RESEARCH PLC

https://www.edenresearch.com/

Eden Research plc develops and supplies sustainable biopesticides and plastic-free encapsulation technologies. The company's core innovation is its proprietary Sustaine® microencapsulation system, which protects and delivers naturally occurring, plant-based active ingredients known as terpenes. Its products serve three primary markets: crop protection, animal health, and consumer products. The crop protection portfolio includes the biofungicide Mevalone® and the bionematicide Cedroz®, designed for applications such as foliar disease control, soil pest management, and post-harvest treatments. In animal health and consumer goods, its technologies are used in products like shampoos, flea and tick control, deodorants, and head-lice treatments.

Recent filings

Filing Released Lang Actions
Placing, Subscription & Open Offer
Capital/Financing Update Classification · 98% confidence The document is an official announcement from Eden Research Plc, identified by the RNS Number (5376E) and the date (28 February 2020). The core subject is the announcement of a 'Placing, Subscription & Open Offer' to raise £10.1 million, detailing the number of shares, the issue price, and the intended use of proceeds. This activity directly relates to fundraising, capital structure changes, and financing activities. This aligns perfectly with the definition for Capital/Financing Update (CAP). Although it is an RNS announcement, the primary content is the financing event itself, making CAP a more specific classification than the general RNS fallback.
2020-02-28 English
Appointment of Hawthorn Advisors
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 2128A' and is dated '20 January 2020'. It announces the 'Appointment of Hawthorn Advisors as its Financial and Corporate Public Relations Adviser'. This type of announcement, which is a general corporate update distributed via the London Stock Exchange's news service (RNS), fits best under the general Regulatory Filings category (RNS), as it does not specifically match definitions for earnings (ER), management changes (MANG), or director dealings (DIRS). Although it is an announcement about appointing an advisor, it is a broad regulatory disclosure.
2020-01-20 English
Year-end trading update
Earnings Release Classification · 98% confidence The document begins with an 'RNS Number' and is dated January 14, 2020. It is titled 'Year-end trading update' and provides unaudited financial highlights (Revenue, Loss before tax) for the year ended December 31, 2019. This content structure—a brief update on recent performance, often preceding a full report—is characteristic of an Earnings Release (ER). However, the document is distributed via RNS, which is the news service of the London Stock Exchange, and the entire text is presented as a regulatory announcement. Since it provides key financial highlights for a period (year-end 2019) but is not the comprehensive Annual Report (10-K) or a detailed Interim Report (IR), it fits best as an Earnings Release (ER). The presence of the RNS header and the nature of the content (trading update with key figures) confirms it is a formal announcement of results. FY 2019
2020-01-14 English
Agreement with Corteva Agriscience
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated 08 January 2020. It announces a specific corporate event: signing a one-year exclusive Evaluation Agreement with Corteva Agriscience regarding seed treatments. The text explicitly states, 'Upon the publication of this Announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.' The presence of the RNS number, the nature of the announcement (a material business development), and the explicit reference to publication via the Regulatory Information Service strongly indicate this is a general regulatory announcement. Since it is not a full financial report (10-K, IR), a specific management change (MANG), or a dividend notice (DIV), the most appropriate classification is the general regulatory filing category, RNS.
2020-01-08 English
Regulatory Approval- Organic Production Regulation
Environmental & Social Information Classification · 99% confidence The document begins with an 'RNS Number' and is dated '07 January 2020'. It announces a specific corporate event: the approval of Eden Research plc's active ingredients under the EU's Organic Production Regulation. This format—a brief announcement of a material event, often referencing an RNS number and providing contact details for PR/Advisors—is characteristic of a general regulatory news service release. Since the content is a specific operational/regulatory update that doesn't fit the definitions for ER, IR, 10-K, or a specific transaction (like DIV or DIRS), the most appropriate classification is the general regulatory filing category, RNS.
2020-01-07 English
Agreement with Sipcam Oxon in Portugal and Benelux
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and is dated 23 December 2019. It announces a new distribution agreement between Eden Research plc and Sipcam Oxon. The text explicitly states: 'The information contained within this announcement (the "Announcement") is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this Announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.' Furthermore, the footer explicitly mentions: 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This structure and explicit reference to RNS strongly indicate a general regulatory announcement that does not fit the more specific categories like 10-K, ER, or DIV. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (9033 chars) is substantial, but the content is a specific business update disseminated via the RNS system, making RNS the best fit over RPA (which is usually an announcement *about* a report).
2019-12-23 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.